Why Peptides Need to Be Reconstituted
Research peptides are supplied in lyophilised (freeze-dried) form. Lyophilisation removes water from the peptide solution under vacuum, leaving behind a stable powder that resists degradation far better than a liquid would during storage and transport. This is why almost every research peptide — from BPC-157 to Semax to GHK-Cu — arrives as a powder rather than a ready-to-use solution.
Before a lyophilised peptide can be used in any laboratory protocol, it must be returned to liquid form. This process is called reconstitution, and it involves adding a specific volume of a sterile diluent to the vial to dissolve the powder back into solution at a known, precise concentration.
Bacteriostatic water is the standard diluent for peptide reconstitution rather than plain sterile water. It contains 0.9% benzyl alcohol as a preservative, which inhibits bacterial growth in the reconstituted solution — extending its usable window compared to water with no preservative, which should be used within hours.
Bacteriostatic Water vs Sterile Water
Both bacteriostatic water and sterile water are laboratory diluents, but they are not interchangeable.
Both are pharmaceutical-grade, particle-free diluents. The difference is the benzyl alcohol preservative in bacteriostatic water, which is what allows a reconstituted peptide solution to remain usable for multiple research sessions rather than requiring fresh reconstitution every time.
Sterile water without a preservative is typically only used for single-use protocols where the entire reconstituted volume will be used immediately, since bacterial growth becomes a risk within a matter of hours once the vial has been opened.
When Water Will Not Dissolve It
Most of the peptides a UK researcher handles day to day go into bacteriostatic water without complaint. Some will not, and when that happens the usual reaction is to add more water, swirl harder, or conclude the vial is bad. All three are wrong, and the last one is expensive.
Solubility is a property of the sequence, not of the vial. A peptide that refuses to dissolve in water is usually behaving exactly as its amino acid composition predicts. The standard laboratory approach, set out in Merck's published solubility guidelines, is to work out the net charge first and choose the solvent to match.
Step one: work out the net charge
Take the sequence and score it at pH 7:
- Score minus one for every acidic residue: aspartic acid (D), glutamic acid (E), and the C-terminal COOH group.
- Score plus one for every basic residue: lysine (K), arginine (R), and the N-terminal NH2 group.
- Score plus one for each histidine (H) below pH 6, and zero above it.
- Add the scores together. The total is the net charge.
Step two: match the solvent to the charge
| Net charge at pH 7 | What to use |
|---|---|
| Negative, acidic peptide | Dissolve in a small amount of 0.1M ammonium bicarbonate, then dilute with water to roughly pH 7 |
| Positive, basic peptide | Dissolve in a small amount of 25 per cent acetic acid, then dilute with water |
| Near neutral, under 10 per cent charged residues | Water alone will often fail. An organic solvent is indicated, such as DMSO, acetonitrile or DMF, added sparingly before diluting |
| Strongly hydrophobic | Dissolve in the organic solvent first, at the smallest volume that works, then bring to final volume with buffer |
Sequences containing cysteine (C) or methionine (M) are unstable in DMSO. Both residues oxidise readily and DMSO accelerates it. If a peptide contains either, an organic solvent is the last option rather than the first, and any solution made that way should be used promptly rather than stored.
Step three: test a small amount before committing the vial
This is the step that gets skipped, and it is the one that saves material. Test a small portion of the powder in the intended solvent before adding solvent to the whole vial. If it dissolves, proceed. If it does not, a fraction of a vial has been lost rather than all of it, and the option of trying a different solvent is still open.
Brief sonication helps. It breaks the solid into smaller particles and speeds dissolution without the mechanical damage that comes from shaking. A short spell in an ultrasonic bath is standard practice and is not the same thing as agitating a vial by hand.
A peptide that will not dissolve in water is not necessarily a bad peptide. It is usually a peptide in the wrong solvent.
Merck solubility guidelines for synthetic peptidesWorking Out the Volume
The arithmetic is simple, and it is worth being able to do it unaided so that any calculator can be sanity-checked. Concentration equals the mass in the vial divided by the volume of diluent added.
Concentration in mg per ml = peptide mass in mg, divided by diluent volume in ml
A 10mg vial with 2ml of bacteriostatic water gives 5mg per ml. The same vial with 1ml gives 10mg per ml. Nothing about the peptide changes, only the concentration of the solution made and therefore the volume drawn for a given quantity.
Two practical points follow. A smaller diluent volume makes a more concentrated solution and means drawing very small volumes, where the error on a syringe graduation becomes a larger proportion of the amount drawn. And the mass printed on the label is not necessarily the mass of peptide in the vial, because salt content and residual water both count towards gross weight. Our guide to what peptide purity figures actually mean explains why a 99 per cent pure 10mg vial does not contain 9.9mg of peptide.
Our peptide reconstitution calculator does the arithmetic for any vial size, diluent volume and target amount, and shows the resulting syringe draw in units as well as millilitres.
How to Reconstitute Peptides — Step by Step
The reconstitution process itself is straightforward once you know the correct volume for your target concentration. Our peptide reconstitution calculator works out the exact bacteriostatic water volume, resulting concentration, and syringe dose for you — but the physical steps below apply regardless of which peptide or concentration you're working with.
Preparation
Allow the vial to reach room temperature before opening. Clean the rubber stopper with an alcohol swab and allow it to dry completely before inserting a needle.
Draw the Bacteriostatic Water
Using a syringe, draw up the exact volume of bacteriostatic water calculated for your target concentration. A larger 3–5 mL syringe with a 23–27 gauge needle is standard for this step.
Add Slowly, Down the Side
Insert the needle through the stopper and let the water run gently down the inside wall of the vial rather than injecting it directly onto the powder. This reduces the risk of denaturing the peptide structure.
Swirl, Don't Shake
Gently swirl the vial to help the powder dissolve. Never shake a peptide vial — vigorous agitation can damage the peptide's structure and reduce its integrity for research use.
Check the Solution
A correctly reconstituted peptide solution should be clear and colourless (GHK-Cu is the exception, presenting as a pale blue solution due to its copper complex). Any cloudiness or visible particulate should not be used.
Never shake a reconstituted peptide vial. The mechanical agitation involved in shaking can break peptide bonds and denature the structure, even when the concentration and volume are otherwise correct.
Standard laboratory reconstitution practiceThe Loss Nobody Accounts For
There is a failure mode in peptide work that produces no cloudiness, no discolouration and no visible clue at all. The solution looks perfect. The concentration is simply not what the arithmetic says it is, because a proportion of the peptide is stuck to the inside of the container.
Peptides adsorb to glass and plastic. Work published in PLOS ONE measured this directly with three cationic peptides and found that under dilute conditions, ninety per cent or more can be lost from solution to the container walls. At 1 micromolar in 220 microlitres over one hour, recovery from borosilicate glass vials and polypropylene tubes was only ten to twenty per cent. Quartz cuvettes returned fifty per cent or less.
Those figures apply at micromolar concentrations in small volumes. They are not what happens in a freshly reconstituted 5mg per ml vial, where there is so much peptide that the surface saturates almost immediately and the proportion lost is negligible. The problem appears when you dilute down for an assay, and it appears silently.
That distinction is the useful part. Reconstitution at working strength is largely unaffected. The serial dilution afterwards is where material disappears, and it is also the step at which a researcher is most likely to assume the concentration is exactly what was calculated.
What reduces the loss
| Measure | Effect |
|---|---|
| Low-bind tubes | Substantially lower adsorption than standard polypropylene. The single most effective routine change |
| Higher concentration | Surface saturates, so the proportion lost falls sharply. Dilute late rather than early |
| Larger volumes | Lower surface-to-volume ratio means proportionally less contact with the wall |
| Fewer transfers | Every container change is another surface. Minimise the number of vessels the solution touches |
| Adjusting ionic strength | Little measurable benefit in the published work. Not worth the effort |
The practical rule is to keep the peptide concentrated for as long as possible, dilute immediately before use rather than in advance, and use low-bind consumables once you are working below roughly micromolar. None of this is exotic and all of it is cheaper than an experiment that quietly ran at a fifth of the intended concentration.
Peptide Storage After Reconstitution
Storage requirements change once a peptide has been reconstituted. Before reconstitution, lyophilised powder is relatively stable and can tolerate short periods at room temperature during transport. After reconstitution, the peptide is in an aqueous environment and becomes significantly more vulnerable to degradation from heat, light and time.
| Stage | Storage Requirement |
|---|---|
| Unreconstituted Powder — Short Term | 2–8°C |
| Unreconstituted Powder — Long Term | -20°C |
| Reconstituted Solution | 2–8°C, refrigerated at all times |
| Reconstituted Shelf Life | Use within the timeframe indicated for your specific peptide and diluent |
| Light Exposure | Protect from direct light — store in original packaging or amber vial where possible |
Once reconstituted, a peptide solution should never be left at room temperature for extended periods and should not be frozen and thawed repeatedly, as freeze-thaw cycling can damage peptide structure over multiple cycles.
Freeze-Thaw and Aliquoting
Every freeze-thaw cycle costs a little material. Ice crystal formation and the concentration changes that accompany freezing both stress peptide structure, and the damage accumulates. One cycle is rarely a problem. Six cycles on the same vial is a different matter, and it is the most common way a solution degrades without anyone noticing.
The fix is to aliquot. Divide the reconstituted solution into single-use portions immediately after reconstitution, freeze those, and thaw one at a time. The stock is then exposed to exactly one cycle instead of one per use.
Lyophilised peptide is hygroscopic. Take a vial straight from cold storage, open it, and the cold surfaces pull moisture out of the room air and into the powder. Let the closed vial reach room temperature before you remove the lid or pierce the stopper. It costs ten minutes and it protects the powder you have not used yet.
The same logic applies to the unopened stock. Merck's handling guidance is that lyophilised peptide should be held at 4 degrees Celsius or colder and away from bright light, with minus 20 or colder for extended storage. Ambient temperature is tolerated for days to weeks, which is what makes cold-chain shipping practical, but not for months.
Which Sequences Degrade Fastest
Not all peptides are equally fragile, and the differences are predictable from the sequence. Four categories are worth knowing before deciding how long a solution can be kept.
| Residues involved | What happens |
|---|---|
| Cysteine (C), Methionine (M) | The main residues that undergo oxidation. Air exposure and DMSO both accelerate it |
| N, Q, C, M and W | Peptides containing these are unstable when stored in solution. Make them fresh where the protocol allows |
| Asp-Pro and Asp-Gly pairs | Particularly susceptible to hydrolysis. A D next to a P or a G is a weak point in the chain |
| Everything else | Generally tolerant of normal refrigerated storage for the stated window |
The practical use of this table is deciding what to aliquot and what to make fresh. A sequence carrying a methionine and an Asp-Gly pair is one you reconstitute in the smallest sensible volume and use quickly. A sequence with none of those features can sit refrigerated for its full stated window without much concern.
Signs Something Has Gone Wrong
Not every reconstitution goes perfectly, and recognising the warning signs early prevents wasted material and unreliable research results.
A cloudy or discoloured solution, visible particulate that doesn't dissolve after gentle swirling, or a solution that develops cloudiness after a period in the fridge are all signs the peptide should not be used. When in doubt, don't use it — reconstitution materials are inexpensive relative to the cost of unreliable research data.
Cloudy solution: Usually indicates the peptide hasn't fully dissolved, or in rarer cases, that the peptide has denatured. Try gently swirling for longer before concluding the batch is compromised.
Incomplete dissolution: If visible powder or particulate remains after several minutes of gentle swirling, the diluent volume may be insufficient, or the vial may need slightly more time at room temperature before reconstitution.
Discolouration: Any colour change beyond what's expected for that specific peptide (GHK-Cu's pale blue being the known exception) suggests the material has degraded and should not be used for research purposes.
Every peptide we supply is independently tested by Janoshik Analytical before dispatch, and stored in pharmaceutical-grade refrigeration throughout our supply chain. Use our reconstitution calculator to work out the exact bacteriostatic water volume for your specific peptide and target concentration.
Worked Examples by Peptide
The method is the same for every compound. Only the arithmetic changes, and the arithmetic depends on the vial size and the concentration you want to end up with. Two millilitres of bacteriostatic water is a common working choice because it gives convenient draw volumes on a standard insulin syringe, but there is nothing special about it.
| Vial | With 1ml / 2ml / 3ml of diluent |
|---|---|
| GHK-Cu 50mg | 50 / 25 / 16.7 mg per ml |
| PT-141 10mg | 10 / 5 / 3.3 mg per ml |
| KPV 10mg | 10 / 5 / 3.3 mg per ml |
| MOTS-c 10mg | 10 / 5 / 3.3 mg per ml |
| Kisspeptin-10 10mg | 10 / 5 / 3.3 mg per ml |
| Selank 10mg | 10 / 5 / 3.3 mg per ml |
| Melanotan I 10mg | 10 / 5 / 3.3 mg per ml |
| Semax 10mg | 10 / 5 / 3.3 mg per ml |
| Ipamorelin 5mg | 5 / 2.5 / 1.7 mg per ml |
| Semax 5mg | 5 / 2.5 / 1.7 mg per ml |
How to reconstitute GHK-Cu
A 50mg GHK-Cu vial with 2ml of bacteriostatic water gives 25mg per ml. GHK-Cu is the one compound where a coloured solution is correct rather than a warning sign: the copper complex produces a pale blue solution. Clear blue is expected. Cloudy blue is not.
How to reconstitute PT-141
A 10mg PT-141 vial with 2ml gives 5mg per ml, which is a common working strength. The finished solution should be clear and colourless.
How to reconstitute Ipamorelin
A 5mg Ipamorelin vial with 2ml gives 2.5mg per ml. Because the vial mass is lower, the same diluent volume produces a more dilute solution and correspondingly larger draw volumes.
Every compound listed above is tested by Janoshik Analytical before it is dispatched, and every vial carries a QR code linking to that batch's certificate, verifiable on the testing laboratory's own portal rather than ours. Stock is held in the UK at 2 to 8 degrees Celsius with continuous logged monitoring. See our lab reports for the current certificates.
Mistakes We See Most Often
Five recur often enough to be worth naming.
Shaking the vial
Agitation shears peptide structure. Swirl gently, or sonicate briefly if something is slow to dissolve. If a vial has been shaken hard there is no way to tell by looking whether damage has occurred, which is precisely the problem.
Injecting the diluent straight onto the powder
A jet of water directed at the cake is unnecessary force. Angle the needle so the diluent runs down the inside wall and reaches the powder gently.
Opening a cold vial
Condensation forms on cold surfaces and lyophilised powder is hygroscopic. Let the closed vial reach room temperature first.
Diluting early and storing dilute
Dilute solutions lose proportionally more material to container walls and degrade faster. Keep the stock concentrated and dilute immediately before use.
Assuming the label mass is the peptide mass
Gross weight includes counter-ion salt and residual water. A calculation based on label mass slightly overstates concentration on every peptide, every time.
Frequently Asked Questions
Can I use tap water, bottled water or distilled water?
No. None of them are sterile or particle-free, and distilled water is not the same as water for injection. Use bacteriostatic water or sterile water for injection. This is not a detail worth economising on when the diluent costs a few pounds.
How long does a reconstituted peptide last?
It depends on the sequence and the diluent. Bacteriostatic water contains benzyl alcohol as a preservative, which controls bacterial growth and gives a longer usable window than preservative-free water, where the limit is hours rather than weeks. Sequences containing N, Q, C, M or W are the least stable in solution and should be used soonest. Keep the solution refrigerated and out of light throughout.
What is the difference between bacteriostatic water and sterile water?
Bacteriostatic Water for Injection USP contains benzyl alcohol, typically 0.9 per cent in plastic vials or 1.1 per cent in glass, at a pH of around 5.7. Sterile Water for Injection contains no preservative. The preservative is what allows a vial to be entered more than once without bacterial growth becoming the limiting factor.
The powder will not dissolve. Is the vial bad?
Usually not. Work out the net charge of the sequence first. Acidic peptides need a small amount of 0.1M ammonium bicarbonate before dilution, basic peptides need a small amount of 25 per cent acetic acid, and near-neutral or hydrophobic sequences may need an organic solvent. Test a small portion before committing the whole vial, and try brief sonication before concluding anything.
Can I refreeze a reconstituted peptide?
Once is usually tolerable, repeatedly is not. Each freeze-thaw cycle causes a little degradation and the effect accumulates. Aliquot into single-use portions immediately after reconstitution so the stock only ever sees one cycle.
There is barely any powder visible in the vial. Have I been short-changed?
Not necessarily. Lyophilised cake volume depends on the freeze-drying cycle and the excipients present, not only on peptide mass, so two vials with the same labelled quantity can look very different. Our guide to why lyophilised vials look different covers this in full. The certificate of analysis, not the appearance, is what tells you what is in the vial.
Why is my GHK-Cu solution blue?
Because it contains copper. GHK-Cu is a copper complex and a pale blue solution is the expected result, not a fault. It is the one common exception to the rule that a correctly reconstituted peptide solution should be clear and colourless.
References
- Merck (Sigma-Aldrich). Solubility Guidelines for Peptides. Net charge calculation and solvent selection.
- Merck (Sigma-Aldrich). Storage and Handling of Synthetic Peptides. Storage temperatures, hygroscopicity, freeze-thaw and residue stability.
- Kristensen K, Henriksen JR, Andresen TL. Adsorption of Cationic Peptides to Solid Surfaces of Glass and Plastic. PLOS ONE. Quantified peptide loss to container surfaces.
- US National Library of Medicine, DailyMed. Bacteriostatic Water for Injection USP label. Composition, benzyl alcohol content and pH.